{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:46:26Z","timestamp":1760057186202,"version":"build-2065373602"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ajem.2018.01.066","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T17:46:41Z","timestamp":1517507201000},"page":"1070-1078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Emergency medicine considerations in atrial fibrillation"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-8869","authenticated-orcid":false,"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurian","family":"Maliel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin R.","family":"Warix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajem.2018.01.066_bb0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1755738014541425","article-title":"Atrial fibrillation","volume":"8","author":"McCartney","year":"2015","journal-title":"InnovAiT"},{"key":"10.1016\/j.ajem.2018.01.066_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"2","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487315571890","article-title":"European primary care cardiovascular society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care","volume":"23","author":"Hobbs","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajem.2018.01.066_bb0020","doi-asserted-by":"crossref","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Albers","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0025","article-title":"Heart disease and stroke statistics-2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2018.01.066_bb0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.annemergmed.2013.06.005","article-title":"A population-based description of atrial fibrillation in the emergency department, 2002 to 2010","volume":"62","author":"Atzema","year":"2013","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.hrtlng.2014.10.005","article-title":"Inflammation-induced atrial fibrillation: pathophysiological perspectives and clinical implications","volume":"44","author":"Al-Zaiti","year":"2015","journal-title":"Heart Lung"},{"key":"10.1016\/j.ajem.2018.01.066_bb0040","article-title":"AHA\/ACC\/HRS guidelines for the management of patients with atrial fibrillation: executive summary","volume":"2014","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ajem.2018.01.066_bb0045","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.ajem.2018.01.066_bb0050","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 Focused update of the ESC guidelines for the management of atrial fibrillation","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajem.2018.01.066_bb0055","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0060","first-page":"74","article-title":"Canadian cardiovascular society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter","volume":"27","author":"Cairns","year":"2011","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.ajem.2018.01.066_bb0065","first-page":"1170","article-title":"2016 Focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"issue":"23","key":"10.1016\/j.ajem.2018.01.066_bb0070","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1161\/CIRCULATIONAHA.113.002449","article-title":"Incident atrial fibrillation among Asians, Hispanics, blacks and whites","volume":"128","author":"Dewland","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ehj.2014.03.004","article-title":"Update on atrial fibrillation","volume":"66","author":"Shenasa","year":"2014","journal-title":"The Egyptian Heart Journal"},{"issue":"10","key":"10.1016\/j.ajem.2018.01.066_bb0080","first-page":"1114","article-title":"2014 Focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation","volume":"30","author":"Verma","year":"2014","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.ajem.2018.01.066_bb0085","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation","volume":"111","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.annemergmed.2007.03.007","article-title":"Increasing US emergency department visit rate and subsequent hospital admissions for atrial fibrillation from 1993 to 2004","volume":"51","author":"Mcdonald","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"Suppl. 5","key":"10.1016\/j.ajem.2018.01.066_bb0095","doi-asserted-by":"crossref","first-page":"v121","DOI":"10.1093\/europace\/eus280","article-title":"Individualized therapy in patients with atrial fibrillation: new look at atrial fibrillation","volume":"14","author":"Shenasa","year":"2012","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ajem.2018.01.066_bb0100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/hrt.2009.176321","article-title":"Lone atrial fibrillation: what do we know?","volume":"96","author":"Kozlowski","year":"2010","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ajem.2018.01.066_bb0105","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/HJR.0b013e32833a1947","article-title":"Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis","volume":"17","author":"Samokhvalov","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mhj.2001.119370","article-title":"Subclinical hyperthyroidism as a risk factor for atrial fibrillation","volume":"142","author":"Auer","year":"2001","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MEJ.0000000000000198","article-title":"The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the emergency department","volume":"22","author":"Hamilton","year":"2015","journal-title":"Eur J Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2018.01.066_bb0120","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation pathophysiology and therapy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.ajem.2018.01.066_bb0125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s13054-014-0688-5","article-title":"Incidence, risk factors and outcomes of new onset atrial fibrillation in patients with sepsis: a systematic review","volume":"18","author":"Kuipers","year":"2014","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0130","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jelectrocard.2014.07.007","article-title":"An atypical case of vagally mediated atrial fibrillation in an elderly woman: electrocardiographic caveats to diagnosis","volume":"47","author":"Sriram","year":"2014","journal-title":"J Electrocardiol"},{"issue":"8","key":"10.1016\/j.ajem.2018.01.066_bb0135","first-page":"OD05","article-title":"Atrial fibrillation due to over the counter stimulant drugs in a young adult","volume":"9","author":"Thyagarajan","year":"2015","journal-title":"JCDR"},{"issue":"8","key":"10.1016\/j.ajem.2018.01.066_bb0140","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1172\/JCI46315","article-title":"Recent advances in the molecular pathophysiology of atrial fibrillation","volume":"121","author":"Wakili","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajem.2018.01.066_bb0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2014.09.012","article-title":"Emergency department patients with atrial fibrillation or flutter and an acute underlying medical illness may not benefit from attempts to control rate or rhythm","volume":"65","author":"Scheuermeyer","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2018.01.066_bb0150","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.annemergmed.2014.12.010","article-title":"Managing atrial fibrillation","volume":"65","author":"Atzema","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2018.01.066_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2010.07.005","article-title":"Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments","volume":"57","author":"Stiell","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2018.01.066_bb0160","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0735-1097(00)00828-7","article-title":"Incidence and predictors of myocardial infarction among patients with atrial fibrillation","volume":"36","author":"Zimetbaum","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2018.01.066_bb0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ajem.2006.09.015","article-title":"The risk for acute coronary syndrome associated with atrial fibrillation among ED patients with chest pain syndromes","volume":"25","author":"Brown","year":"2007","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajem.2018.01.066_bb0175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-126-8-199704150-00005","article-title":"Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours","volume":"126","author":"Weigner","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajem.2018.01.066_bb0180","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1197\/j.aem.2007.07.016","article-title":"Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter","volume":"14","author":"Stiell","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1481803500012227","article-title":"Association of the Ottawa aggressive protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter","volume":"12","author":"Stiell","year":"2010","journal-title":"CJEM"},{"issue":"23","key":"10.1016\/j.ajem.2018.01.066_bb0190","first-page":"9e241","article-title":"Safety of urgent cardioversion for patients with recent-onset atrial fibrillation and flutter","volume":"31","author":"Stiell","year":"2015","journal-title":"Can J Cardiol"},{"issue":"23","key":"10.1016\/j.ajem.2018.01.066_bb0195","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajem.2018.01.066_bb0200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ahj.2004.09.038","article-title":"Clinical factors that influence response to treatment strategies in atrial fibrillation: the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study","volume":"149","author":"AFFIRM investigators","year":"2005","journal-title":"Am Heart J"},{"issue":"23","key":"10.1016\/j.ajem.2018.01.066_bb0205","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ajem.2018.01.066_bb0210","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0215","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.165.3.258","article-title":"Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis","volume":"165","author":"de Denus","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajem.2018.01.066_bb0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1540-8159.2012.03513.x","article-title":"Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis","volume":"36","author":"Chatterjee","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ajem.2018.01.066_bb0225","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1536\/jhj.45.591","article-title":"Comparison of rate and rhythm control in patients with atrial fibrillation and nonischemic heart failure","volume":"45","author":"Okcun","year":"2004","journal-title":"Japan Heart J"},{"key":"10.1016\/j.ajem.2018.01.066_bb0230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1253\/circj.CJ-08-0608","article-title":"Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM study","volume":"73","author":"Ogawa","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.ajem.2018.01.066_bb0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0196-0644(99)70300-8","article-title":"Cardioversion of paroxysmal atrial fibrillation in the emergency department","volume":"33","author":"Michael","year":"1999","journal-title":"Ann Emerg Med"},{"issue":"13","key":"10.1016\/j.ajem.2018.01.066_bb0240","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (FinnishCardioVersion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajem.2018.01.066_bb0245","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajem.2016.05.012","article-title":"Safety and efficacy of pharmacological cardioversion of recent-onset atrial fibrillation: a single-center experience","volume":"34","author":"Kriz","year":"2016","journal-title":"Am J Emerg Med"},{"issue":"12","key":"10.1016\/j.ajem.2018.01.066_bb0250","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.amjcard.2007.01.057","article-title":"Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation","volume":"99","author":"Onalan","year":"2007","journal-title":"Am J Cardiol"},{"issue":"22","key":"10.1016\/j.ajem.2018.01.066_bb0255","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/ajhp\/60.22.2308","article-title":"Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter","volume":"60","author":"Kalus","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ajem.2018.01.066_bb0260","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0002-9149(79)90456-9","article-title":"Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent","volume":"44","author":"David","year":"1979","journal-title":"Am J Cardiol"},{"author":"National Library of Medicine","key":"10.1016\/j.ajem.2018.01.066_bb0265"},{"key":"10.1016\/j.ajem.2018.01.066_bb0270","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.65.2.348","article-title":"Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil","volume":"65","author":"Gulamhusein","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2018.01.066_bb0275","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2018.01.066_bb0280","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ajem.2018.01.066_bb0285","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(89)90141-0","article-title":"Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter","volume":"63","author":"Platia","year":"1989","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ajem.2018.01.066_bb0290","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/emj.2003.012047","article-title":"Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation","volume":"22","author":"Demircan","year":"2005","journal-title":"Emerg Med J"},{"issue":"2","key":"10.1016\/j.ajem.2018.01.066_bb0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm","year":"2015","journal-title":"J Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2018.01.066_bb0300","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jemermed.2010.05.017","article-title":"Managing emergency department patients with recent-onset atrial fibrillation","volume":"42","author":"Vinson","year":"2012","journal-title":"J Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0305","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MEJ.0000000000000227","article-title":"\u03b2-blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review","volume":"22","author":"Martindale","year":"2015","journal-title":"Eur J Emerg Med"},{"issue":"9169","key":"10.1016\/j.ajem.2018.01.066_bb0310","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ajem.2018.01.066_bb0315","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9149(90)90351-Z","volume":"66","year":"1990","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ajem.2018.01.066_bb0320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","author":"The Multicenter Diltiazem Postinfarction Trial Research Group","year":"1988","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ajem.2018.01.066_bb0325","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ajem.2018.01.066_bb0330","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1001\/jama.1983.03330420058038","article-title":"The use of beta-blockers after myocardial infarction","volume":"249","author":"Turi","year":"1983","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0335","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/01.HYP.0000231662.77359.de","article-title":"Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"48","author":"Leenen","year":"2006","journal-title":"Hypertension"},{"issue":"2\u20133","key":"10.1016\/j.ajem.2018.01.066_bb0345","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0167-5273(01)00450-8","article-title":"Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation","volume":"79","author":"Chiladakis","year":"2001","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ajem.2018.01.066_bb0350","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.annemergmed.2004.09.013","article-title":"A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation","volume":"45","author":"Davey","year":"2005","journal-title":"Ann Emerg Med"},{"issue":"8","key":"10.1016\/j.ajem.2018.01.066_bb0355","first-page":"529","article-title":"Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias","volume":"43","author":"Joshi","year":"1995","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0360","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/clc.4960160512","article-title":"The effect of magnesium versus verapamil on supraventricular arrhythmias","volume":"16","author":"Gullestad","year":"1993","journal-title":"Clin Cardiol"},{"issue":"11","key":"10.1016\/j.ajem.2018.01.066_bb0365","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/hrt.2006.111492","article-title":"Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis","volume":"93","author":"Ho","year":"2007","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ajem.2018.01.066_bb0370","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1553-2712.2009.00360.x","article-title":"Magnesium sulfate versus placebo for paroxysmal atrial fibrillation: a randomized clinical trial","volume":"16","author":"Chu","year":"2009","journal-title":"Acad Emerg Med"},{"issue":"25","key":"10.1016\/j.ajem.2018.01.066_bb0375","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.jacc.2016.03.581","article-title":"Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke","volume":"67","author":"Hsu","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ajem.2018.01.066_bb0380","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajem.2018.01.066_bb0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest J"},{"key":"10.1016\/j.ajem.2018.01.066_bb0390","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ajem.2012.04.005","article-title":"New oral anticoagulants in the ED setting: a review","volume":"30","author":"Pollack","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"10","key":"10.1016\/j.ajem.2018.01.066_bb0395","first-page":"1","article-title":"Emergency department management of patients on novel oral anticoagulant agents","volume":"15","author":"Raja","year":"2013","journal-title":"Emerg Med Pract"},{"issue":"9921","key":"10.1016\/j.ajem.2018.01.066_bb0400","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2018.01.066_bb0405","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jth.12227","article-title":"The role of the laboratory in treatment with new oral anticoagulants","volume":"11","author":"Baglin","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"24","key":"10.1016\/j.ajem.2018.01.066_bb0410","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ajem.2018.01.066_bb0415","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajem.2018.01.066_bb0420","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ajem.2018.01.066_bb0425","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Guigliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0430","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.amjcard.2012.03.049","article-title":"Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation","volume":"110","author":"Miller","year":"2012","journal-title":"Am J Cardiol"},{"issue":"11S","key":"10.1016\/j.ajem.2018.01.066_bb0435","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.amjmed.2016.06.004","article-title":"Safety of direct oral anticoagulants: insights from postmarketing studies","volume":"129","author":"Villines","year":"2016","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ajem.2018.01.066_bb0440","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ajem.2018.01.066_bb0445","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0450","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1378\/chest.12-0608","article-title":"Predictive value of the has-bled and atria bleeding scores for the risk of serious bleeding in a \u201cReal-World\u201d population with atrial fibrillation receiving anticoagulant therapy","volume":"143","author":"Rold\u00e1n","year":"2013","journal-title":"Chest"},{"issue":"9342","key":"10.1016\/j.ajem.2018.01.066_bb0455","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(02)11315-8","article-title":"Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial","volume":"360","author":"Kirchhof","year":"2002","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0460","first-page":"940","article-title":"Preventing hypotension effect of calcium channel blockers","volume":"67","author":"Allen","year":"2003","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0465","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01686855","article-title":"Intravenous calcium chloride as an antidote to verapamil-induced hypotension","volume":"8","author":"Lipman","year":"1982","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0470","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1600-0773.1987.tb01520.x","article-title":"Can blood pressure reduction induced by slow calcium channel blockade (verapamil) be reversed by calcium infusion?","volume":"60","author":"Midtbo","year":"1987","journal-title":"Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.ajem.2018.01.066_bb0475","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0167-5273(83)90084-0","article-title":"The use of calcium with verapamil in the management of supraventricular tachyarrhythmias","volume":"4","author":"Weiss","year":"1983","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ajem.2018.01.066_bb0480","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jemermed.2003.12.020","article-title":"Calcium chloride before IV diltiazem in the management of atrial fibrillation","volume":"26","author":"Kolkebeck","year":"2004","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2010.05.031","article-title":"A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation","volume":"57","author":"Barrett","year":"2011","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2018.01.066_bb0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2014.08.023","article-title":"Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for predicting 30-day adverse events in emergency department patients with atrial fibrillation","volume":"65","author":"Barrett","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2018.01.066_bb0495","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.amjcard.2013.07.005","article-title":"Predictors of regional variations in hospitalizations following emergency department visits for atrial fibrillation","volume":"112","author":"Barrett","year":"2013","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ajem.2018.01.066_bb0500","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.annemergmed.2012.12.022","article-title":"Factors associated with 90 day death after emergency department discharge for atrial fibrillation","volume":"61","author":"Atzema","year":"2013","journal-title":"Ann Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718300809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675718300809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:40:28Z","timestamp":1760024428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675718300809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0735675718300809"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2018.01.066","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency medicine considerations in atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2018.01.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}